Ravee Optics Secures $6.0

Fluent, Inc

Fluent, Inc. (NASDAQ: FLNT) is a commerce media solutions provider connecting top-tier brands with highly engaged consumers. Leveraging exclusive ad inventory, robust first-party data, and proprietary machine learning, Fluent unlocks additional revenue streams for partners and empowers advertisers to acquire their most valuable customers at scale. Founded in 2010, Fluent uses its deep expertise in performance marketing to drive monetization and increase engagement at key touchpoints across the customer journey. For more info, visit https://www.fluentco.com/.

EchoIQ

Echo IQ is an AI-driven clinical decision support company that analyzes routine echocardiographic measurements to support fast, consistent interpretation of echocardiograms. Our first product, EchoSolv™ AS, is an AI platform that analyzes echocardiographic measurements to generate a probability assessment of severe aortic stenosis. EchoSolv™ AS was built using more than 200 million echocardiographic measurements from real-world patient data, drawn from one of the largest echo datasets in the world. It also delivers strong rule-out performance, with a 99.2% negative predictive value. Importantly, EchoSolv™ AS goes beyond current clinical guidelines, identifying high-risk patients who traditional criteria can miss but who show similar five-year mortality to guideline-defined severe AS. For example, in a multi-center study, clinicians initially identified 218 patients with severe AS, while EchoSolv™ AS found an additional 66 cases with elevated severe AS probability outside current guideline criteria. It is FDA-cleared as a Class II medical device (510(k) K241245). Echo IQ’s long-term vision is to expand this measurement-based AI platform to support interpretation of additional structural heart diseases.

Floqer

We streamline and automate sales processes by connecting with CRM, the web data sources, and AI sales tools. Companies use this tool to build AI powered sales funnels, and do strategic account research all in one spot. Common examples are: understanding prospects tech stack to create outbound emails/messages, investigating customer annual reports to find sales opportunities. You can learn more from our website: floqer.com

gMendel

AI-powered, vertically-integrated IVD certified technology for accurate, fast and affordable diagnosis of genetic disorders & beyond. There are 350 million people worldwide suffering from >10,000 genetic disorders / rare diseases, but <500 of these diseases have an approved treatment. The societal burden of the rare diseases exceeds €2 trillion, demonstrating an apparent unmet clinical need for better, faster & affordable Companion Diagnostics of rare diseases towards precision treatments. Today, the diagnosis of rare diseases, that takes on average 7 years, is based on the current sequencing technologies, has a high cost and complexity and leaves many patients undiagnosed. gMendel® is the only end-to-end cloud based technology that uses AI for accurate, fast & affordable diagnosis of multiple rare diseases & beyond. Moreover, gMendel®’s technology is automated, transcending the need for bioinformatician’s intervention, reducing the experimental errors & costs. This improves accessibility and has a potential to revolutionize genetic analysis without any change to current health care protocols. Compared to current available technologies in the market, our novel combination of genomics & AI makes our technology better, faster, and more affordable than any other in the companion diagnostics market. In 2022, gMendel® obtained CE mark under EU IVDD, becoming the world’s first IVD certified technology for human genetic disorders utilizing long read sequencing technology and AI. gMendel® has achieved Proof of Concept to detect deletions, insertions, point mutations by doing whole exome sequencing or DNA region customisation by amplicons or probes. We are currently in the process to commercialise our technology for Companion Diagnostics for Anemia, Epilepsy, Cystic Fibrosis & Spinal Muscular Atrophy.

Klydo.Official

Born in the feed, built for speed, and powered by AI—Klydo is reimagining how India’s 18–32 year-olds discover and shop fashion. Positioned as a fashion discovery feed first and commerce engine second, we make shopping feel like scrolling—AI-personalized, video-led, and delivered in minutes. At the heart of Klydo is our chatbot: part bestie, part stylist, part therapist—helping Gen-Z find not just outfits, but confidence and vibe.